AIMCOPEST
Aimco Pesticides financials
- Market cap
- ₹46 Cr
- Sector
- Chemicals
- Calls analysed
- 1
AIMCOPEST Q4 FY25
What went well
- Brand business continued to perform well, growing 15% in FY25 and targeting 20% growth in FY26.
- Achieved 25% volume growth in active ingredients in FY25 despite flat top-line due to price erosion.
- Received Bifenthrin registration in Brazil, with Triclopyr registration expected soon, targeting ₹100 crores in sales for Triclopyr.
What to watch
- FY25 top-line remained largely flat with marginal degrowth in sales compared to the previous financial year.
- Profitability margins remained under pressure, with EBITDA losses observed and PAT level being negative in FY25.
What Aimco Pesticides Ltd. does
Aimco Pesticides manufactures technical-grade agrochemical actives (insecticides, herbicides and fungicides) at its sole plant in Lote Parshuram, Ratnagiri, Maharashtra, using them captively to make its own formulations or selling them to third-party formulators in India and abroad. Its Branded Formulations business sells its own agrochemical brands (Anaconda, Pyriban, Bykill, Aimcopro, Profenotox) to Indian farmers through branch offices and a distributor network, while its B2B Formulations business supplies bulk and retail-packaged formulations to agrochemical distributors globally. A smaller Trading arm carries out limited, opportunistic trading within its existing product categories.
Segments
- Technical
- Branded Formulations
- B2B Formulations
- Trading
- Manufacturing facilities
- 1 (Lote Parshuram, Ratnagiri, Maharashtra)
- Installed manufacturing capacity
- Technical grade chemicals: 6,000 tonnes/yr; Liquid formulations: 7,000 kilolitres/yr; Granules formulations: 7,000 tonnes/yr
- Branded formulation SKUs
- 305+
- Active distributors (Branded Formulations)
- ~785
- Export footprint
- Exports to ~45 countries; products registered in 100+ countries
- Formulations manufactured
- 90+ (across EC, SC, SL, SG, WDG, WP, DP, GR categories)
Guidance record · Q4 FY25
what the last two calls moved 5 tracked 0 delivered 0 missed 5 open- Top Line Sales open said Q4 FY25 Promised: ₹225 crore Q4 FY25: FY26, we expect sales of about 225 crore top line.
All 5 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue down 54.5%, net profit up 140.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 55 | 51 | 53 | 48 | 46 −18% | 30 −40% | 31 −42% | 22 −55% |
| EBITDA | 0 | 2 | -5 | -1 | -3 −1279% | -2 −203% | -4 +3% | 2 +256% |
| Net profit | -1 | 1 | -5 | -1 | -4 −279% | -3 −587% | -4 +19% | 1 +141% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +7.6% YTD
YTD: ₹7.2 on 24 Feb 2000 → ₹7.75. High ₹11.5 (26 Apr 2000), low ₹5.25 (21 Mar 2000).
Financials, as filed
Revenue fell 13.6% a year over 2 years, FY24 to FY26. Operating margin narrowed to -7.2%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹207 Cr | ₹199 Cr | ₹155 Cr |
| Operating profit | ₹-8 Cr | ₹-3 Cr | ₹-11 Cr |
| Operating margin | -3.6% | -1.3% | -7.2% |
| Interest | ₹3 Cr | ₹3 Cr | ₹2 Cr |
| Depreciation | ₹4 Cr | ₹4 Cr | ₹3 Cr |
| Net profit | ₹-10 Cr | ₹-7 Cr | ₹-12 Cr |
| Net margin | -4.8% | -3.6% | -7.9% |
| Cash from operations | ₹7 Cr | ₹3 Cr | ₹6 Cr |
| Free cash flow | ₹1 Cr | ₹1 Cr | ₹4 Cr |
| ROCE | -18.0% | -12.0% | -34.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
| Reserves | ₹31 Cr | ₹41 Cr | ₹37 Cr | ₹25 Cr | ₹15 Cr | ₹8 Cr |
| Borrowings | ₹11 Cr | ₹0 Cr | ₹14 Cr | ₹19 Cr | ₹17 Cr | ₹15 Cr |
| Other liabilities | ₹81 Cr | ₹116 Cr | ₹86 Cr | ₹95 Cr | ₹96 Cr | ₹97 Cr |
| Total liabilities | ₹133 Cr | ₹167 Cr | ₹146 Cr | ₹150 Cr | ₹137 Cr | ₹130 Cr |
| Fixed assets | ₹19 Cr | ₹25 Cr | ₹28 Cr | ₹26 Cr | ₹29 Cr | ₹24 Cr |
| Capital work in progress | ₹8 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹1 Cr | ₹4 Cr |
| Investments | ₹0 Cr | ₹4 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹106 Cr | ₹134 Cr | ₹113 Cr | ₹118 Cr | ₹107 Cr | ₹101 Cr |
| Total assets | ₹133 Cr | ₹167 Cr | ₹146 Cr | ₹150 Cr | ₹137 Cr | ₹130 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
The ownership split has held steady since Jun 2025. The shareholder count shrank 32% to 7,792.
- Promoters
- 54.5%
- Public
- 45.5%
Since Jun 2025
- Public +0.08 pp
- FIIs −0.04 pp
- DIIs −0.03 pp
How it drifted, 12 quarters
Ownership split by quarter, oldest first. Sep '23: Promoters 53.5%, FIIs 0.0%, DIIs 0.0%, Public 46.4%.Dec '23: Promoters 53.5%, FIIs 0.0%, DIIs 0.0%, Public 46.4%.Mar '24: Promoters 53.5%, DIIs 0.1%, Public 46.4%.Jun '24: Promoters 53.5%, FIIs 0.0%, DIIs 0.0%, Public 46.4%.Sep '24: Promoters 53.5%, DIIs 0.1%, Public 46.4%.Dec '24: Promoters 53.5%, DIIs 0.1%, Public 46.4%.Mar '25: Promoters 54.5%, FIIs 0.0%, DIIs 0.0%, Public 45.5%.Jun '25: Promoters 54.5%, FIIs 0.0%, DIIs 0.0%, Public 45.5%.Sep '25: Promoters 54.5%, FIIs 0.0%, DIIs 0.0%, Public 45.5%.Dec '25: Promoters 54.5%, Public 45.5%.Mar '26: Promoters 54.5%, Public 45.5%.Jun '26: Promoters 54.5%, Public 45.5%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Elizabeth Shrivastava - 2 newly disclosed 0.17% held
The same filing shows 0 holders trimming and 1 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Aimco Pesticides Ltd. above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Amisco Agro-Chem Limited | 29.52% | unchanged |
| Pradeep Pushkarrai Dave | 9.22% | unchanged |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | 4.98% | unchanged |
| Ashit Pradip Dave | 4.93% | unchanged |
| Samir Pradeepbhai Dave | 4.13% | unchanged |
| Damodar Prasad Agarwal | 3.56% | unchanged |
| Lincoln P Coelho | 2.45% | unchanged |
| Priyal Dave | 1.54% | unchanged |
| Shail Samir Dave | 1.53% | unchanged |
| Suman Agarwal | 1.15% | unchanged |
| Shreya Ashit Dave | 0.95% | unchanged |
| Nandini Ashit Dave | 0.94% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Aimco Pesticides Ltd.
Guides on how to read this kind of business and the numbers that matter.